BeiGene
BGNE
#967
Rank
A$32.53 B
Marketcap
$297.34
Share price
0.49%
Change (1 day)
36.75%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Unfortunately we have no cost to borrow data for this company